Chondroitin Side Effects: What the Safety Data Actually Shows

Written by the Nuvirox Research Team

Short answer: chondroitin is one of the better-tolerated joint supplements studied, with honest caveats. In controlled trials it produces side effects at about the same rate as placebo, and those effects are usually mild stomach upset. The cautions that matter are narrower: case reports link glucosamine-chondroitin products to raised INR in people on warfarin, there is a published report of asthma worsening, and there is essentially no safety data for pregnancy. For most healthy adults the bigger practical question is product quality, not toxicity.

What is chondroitin, and why would it cause side effects at all?

Chondroitin sulfate is a large sugar-chain molecule (a glycosaminoglycan) that is a normal part of cartilage. Supplement-grade chondroitin is extracted from animal cartilage, most often bovine (cow), porcine (pig), chicken or shark. Because it is a natural structural molecule rather than a drug designed to block an enzyme or receptor, there is no obvious pharmacological route to strong side effects, and that matches what the trials have found.

Because it is taken by mouth as a large sugar-based molecule, the digestive tract is where people tend to notice any effects first. Whether chondroitin works for joint comfort is a separate question; we cover that in our review of whether chondroitin sulfate works on its own. This article sticks to safety.

What are the most common side effects of chondroitin?

The most commonly reported side effects are mild gastrointestinal ones: nausea, upset stomach, bloating, diarrhea or constipation. In the placebo-controlled trials, these complaints showed up in placebo groups at similar rates, which is why reviewers generally conclude that chondroitin itself adds little or no measurable side-effect burden.

That doesn't mean nobody notices anything. A minority of people find that a full daily dose taken at once on an empty stomach upsets their digestion, and splitting the dose or taking it with food usually solves that. If you take a combination product, remember that the other ingredients have side-effect profiles of their own; our breakdown of glucosamine's side effects covers the partner ingredient chondroitin is most often paired with.

Does chondroitin interact with warfarin or other blood thinners?

Possibly, and this is the most important caution on the list. The evidence comes from case reports and adverse-event databases, not trials, and most cases involve products that combine glucosamine with chondroitin, so it is hard to pin the effect on chondroitin alone. Still, the signal is consistent enough that anyone on warfarin should treat it seriously.

The best-documented case, published by FDA reviewers in 2008, described a 71-year-old man on stable warfarin whose INR rose from 2.3 to 3.9 about three weeks after he tripled his glucosamine-chondroitin dose, and later reached 4.7 before the supplement was stopped. The same paper found 20 FDA MedWatch reports of glucosamine or glucosamine-chondroitin use with warfarin linked to altered clotting, including one serious brain bleed, plus 21 WHO reports of raised INR with glucosamine. We cover blood thinners and other medication questions in more depth in our guide to joint supplement and medication interactions.

Can chondroitin trigger asthma or allergic reactions?

It is rare, but there is a published report. In 2002, family physicians described a patient whose asthma flared after starting a glucosamine-chondroitin supplement, and argued the link was biologically plausible because similar molecules appear in airway secretions. One case cannot establish cause, but it is reasonable for people with poorly controlled asthma to start cautiously and stop if breathing worsens.

Source matters for allergy questions too. Chondroitin itself is not made from shellfish; that concern belongs mainly to glucosamine, which is often derived from crustacean shells. Chondroitin is usually bovine, porcine, chicken or shark-derived, so people who avoid particular animal products for allergy, religious or dietary reasons should check the label or ask the manufacturer for the source species.

What human studies actually show

The Cochrane review (2015). This systematic review pooled 43 randomized trials covering 4,962 people taking chondroitin and 4,148 given placebo or a comparator, with trials lasting from 1 month to 3 years. Chondroitin did not produce statistically more adverse events or withdrawals due to adverse events than control. Serious adverse events were less likely with chondroitin (Peto odds ratio 0.40), roughly 3 versus 6 per 100 people. The review authors also flagged a real weakness: adverse events "were reported in a limited fashion, with some studies providing data and others not."

The GAIT trial (2006). This NIH-funded study randomized 1,583 people with knee osteoarthritis to 1,200 mg/day chondroitin, 1,500 mg/day glucosamine, both, 200 mg/day celecoxib, or placebo for 24 weeks. The investigators reported that adverse events "were mild, infrequent, and evenly distributed among the groups."

The MOVES trial (2016). In 606 people with painful knee osteoarthritis, a pharmaceutical-grade combination of 400 mg chondroitin plus 500 mg glucosamine three times daily was compared with celecoxib for 6 months. Adverse events were low and similar between groups. The full text adds useful context: around half the patients in each group had at least one adverse event, mostly mild or moderate, with 17 events classed as serious across the trial. The authors also cautioned that their results came from a prescription-grade product and may not generalize to supplements sold in the US.

The limiting finding. The reassuring trial data come mostly from carefully screened participants over months, not decades, and frequently from pharmaceutical-grade products. People with high cardiovascular or gastrointestinal risk were excluded from MOVES. The warfarin signal came from outside trials entirely, which is a reminder that rare interactions rarely show up in controlled studies.

What chondroitin's safety record doesn't cover

A clean trial record is not a blanket guarantee. Three gaps are worth stating plainly:

• Pregnancy and breastfeeding. There are no meaningful human safety studies. Absence of evidence isn't evidence of harm, but it's the reason most clinicians recommend avoiding it during these periods.
• Product quality. Chondroitin's makeup depends on source and processing, and several trials above used pharmaceutical-grade material rather than retail supplements.
• Combination products. Many side effects blamed on "chondroitin" may come from glucosamine, MSM or other ingredients in the same capsule.

See a doctor promptly if you notice unusual bruising, bleeding gums, blood in urine or stool, new wheezing or shortness of breath, hives or facial swelling. Also get joint pain itself checked if it comes with redness, heat, significant swelling, fever, or follows an injury, since those aren't things a supplement should be masking.

How to take chondroitin with the least chance of side effects

GAIT and MOVES both used 1,200 mg of chondroitin per day (MOVES split it into three doses) and judged effects over 6 months. Practical steps that line up with that research:

• Take it with a meal, and split the daily amount if a single dose upsets your stomach.
• Stay within trial doses; there's no evidence more works better.
• If you take warfarin, tell your prescriber before starting, stopping or changing the dose, so your INR can be checked.
• Choose products that name the animal source and use third-party testing, since quality varies.
• Give it a fair trial window before judging it, and stop if side effects persist rather than pushing through.

Chondroitin is often stacked with other anti-inflammatory ingredients. If you're considering an enzyme such as bromelain alongside it, it helps to understand bromelain's side-effect profile, which includes a more meaningful bleeding question than chondroitin's.

Frequently asked questions

Can chondroitin hurt your kidneys or liver?

Trial data don't show a kidney or liver signal. The 2019 safety meta-analysis specifically examined renal and urinary adverse events and found no increase with chondroitin versus placebo. If you have existing kidney or liver disease, it's still sensible to clear any supplement with your doctor.

Is chondroitin safe if I'm allergic to shellfish?

Chondroitin itself is generally made from bovine, porcine, chicken or shark cartilage, not shellfish. The shellfish question applies mostly to glucosamine, which is often in the same product. Check the full ingredient list and ask the manufacturer about sources if you have a serious allergy.

Can I take chondroitin long term?

Some trials in the Cochrane review lasted up to three years without a safety signal, which is reassuring. Long-term data from everyday users with multiple medications are thinner, so periodic check-ins with your clinician are reasonable, especially if your medications change.

Why does chondroitin upset my stomach?

Mild digestive upset is the most commonly reported complaint, though trials show placebo groups report it at similar rates. Taking it with food or splitting the dose often helps; if it doesn't, it may not be the right supplement for you.

The bottom line

Chondroitin's side-effect record is genuinely good: across tens of trials and thousands of people, side effects showed up at roughly placebo rates and were usually mild digestive complaints. The cautions that matter are specific rather than general. Warfarin users should involve their prescriber because of a credible INR signal, people with asthma should watch for breathing changes, and pregnant or breastfeeding women have no safety data to rely on. For everyone else, product quality and realistic expectations matter more than toxicity.

References

1. Singh JA, Noorbaloochi S, MacDonald R, Maxwell LJ. Chondroitin for osteoarthritis. Cochrane Database Syst Rev. 2015;1(1):CD005614. DOI: 10.1002/14651858.CD005614.pub2. PMID: 25629804. PMCID: PMC4881293
2. Honvo G, Reginster JY, Rabenda V, et al. Safety of Symptomatic Slow-Acting Drugs for Osteoarthritis: Outcomes of a Systematic Review and Meta-Analysis. Drugs Aging. 2019;36(Suppl 1):65-99. DOI: 10.1007/s40266-019-00662-z. PMID: 31073924. PMCID: PMC6509099
3. Clegg DO, Reda DJ, Harris CL, et al. Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis. N Engl J Med. 2006;354(8):795-808. DOI: 10.1056/NEJMoa052771. PMID: 16495392
4. Hochberg MC, Martel-Pelletier J, Monfort J, et al. Combined chondroitin sulfate and glucosamine for painful knee osteoarthritis: a multicentre, randomised, double-blind, non-inferiority trial versus celecoxib. Ann Rheum Dis. 2016;75(1):37-44. DOI: 10.1136/annrheumdis-2014-206792. PMID: 25589511. PMCID: PMC4717399
5. Knudsen JF, Sokol GH. Potential glucosamine-warfarin interaction resulting in increased international normalized ratio: case report and review of the literature and MedWatch database. Pharmacotherapy. 2008;28(4):540-8. DOI: 10.1592/phco.28.4.540. PMID: 18363538
6. Tallia AF, Cardone DA. Asthma exacerbation associated with glucosamine-chondroitin supplement. J Am Board Fam Pract. 2002;15(6):481-4. PMID: 12463294

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This article is for informational purposes only and is not a substitute for professional medical advice.